These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 16475132)
21. [Comparison of valproate level in human plasma, cerebrospinal fluid and brain tissue following administration of various preparations of valproate and valpromide]. Wieser HG Praxis (Bern 1994); 1994 Oct; 83(40):1111-6. PubMed ID: 7939081 [TBL] [Abstract][Full Text] [Related]
22. [Do results of the recent clinical trials change the place of valproate in treatment of epilepsy?]. Bosak M Przegl Lek; 2008; 65(11):807-9. PubMed ID: 19205366 [TBL] [Abstract][Full Text] [Related]
28. Effects of epilepsy and valproic acid on oxidant status in children with idiopathic epilepsy. Yiş U; Seçkin E; Kurul SH; Kuralay F; Dirik E Epilepsy Res; 2009 Apr; 84(2-3):232-7. PubMed ID: 19261443 [TBL] [Abstract][Full Text] [Related]
29. Population pharmacokinetics of valproate in Mexican children with epilepsy. Correa T; Rodríguez I; Romano S Biopharm Drug Dispos; 2008 Dec; 29(9):511-20. PubMed ID: 19067436 [TBL] [Abstract][Full Text] [Related]
30. [Convulex and its place in epilepsy treatment with original valproates]. Gromov SA; Kim KV Zh Nevrol Psikhiatr Im S S Korsakova; 2002; 102(9):18-21. PubMed ID: 12378876 [TBL] [Abstract][Full Text] [Related]
31. The spectrum of valproic acid-associated pancreatitis. Werlin SL; Fish DL Pediatrics; 2006 Oct; 118(4):1660-3. PubMed ID: 17015559 [TBL] [Abstract][Full Text] [Related]
32. Conversion from delayed-release sodium valproate to extended-release sodium valproate: initial results and long-term follow-up. McCabe PH; Michel NC; McNew CD; Lehman EB Epilepsy Behav; 2006 May; 8(3):601-5. PubMed ID: 16678766 [TBL] [Abstract][Full Text] [Related]
33. Valproate treatment of acute alcohol hallucinosis: a double-blind, placebo-controlled study. Aliyev ZN; Aliyev NA Alcohol Alcohol; 2008; 43(4):456-9. PubMed ID: 18495806 [TBL] [Abstract][Full Text] [Related]
34. Effectiveness and tolerability of rufinamide in children and adults with refractory epilepsy: first European experience. Kluger G; Kurlemann G; Haberlandt E; Ernst JP; Runge U; Schneider F; Makowski C; Boor R; Bast T Epilepsy Behav; 2009 Mar; 14(3):491-5. PubMed ID: 19162229 [TBL] [Abstract][Full Text] [Related]
35. Bioequivalence in development of antiepileptic drugs. Sommerville KW Epilepsy Res; 2006 Jan; 68(1):82-5. PubMed ID: 16377144 [TBL] [Abstract][Full Text] [Related]
36. [The pharmacological and hormonal effects of carbamazepine and valproic acid in the treatment of reproductive age women with epilepsy]. Vlasov PN; Karlov VA; Kushlinskiĭ NE Zh Nevrol Psikhiatr Im S S Korsakova; 2001; 101(11):26-30. PubMed ID: 11765608 [TBL] [Abstract][Full Text] [Related]
37. The effects of carbamazepine, valproic acid and phenobarbital on the oxidative and antioxidative balance in epileptic children. Aycicek A; Iscan A Eur Neurol; 2007; 57(2):65-9. PubMed ID: 17179706 [TBL] [Abstract][Full Text] [Related]
38. Efficacy and tolerability of two formulations of ramipril in Korean adults with mild to moderate essential hypertension: an 8-week, multicenter, prospective, randomized, open-label, parallel-group noninferiority trial. Kim SH; Chung WY; Zo JH; Kim MA; Chang HJ; Cho YS; Youn TJ; Chae IH; Choi DJ; Gwak JJ; Lee HY; Park JS; Kang HJ; Kim YJ; Kim HS Clin Ther; 2009 May; 31(5):988-98. PubMed ID: 19539099 [TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study. Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648 [TBL] [Abstract][Full Text] [Related]
40. Rufinamide: clinical pharmacokinetics and concentration-response relationships in patients with epilepsy. Perucca E; Cloyd J; Critchley D; Fuseau E Epilepsia; 2008 Jul; 49(7):1123-41. PubMed ID: 18503564 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]